MALG vs OKT3 following renal transplantation: a randomized prospective trial

Transplant Proc. 1991 Feb;23(1 Pt 2):1048-9.
No abstract available

Publication types

  • Clinical Trial
  • Randomized Controlled Trial
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Antibodies, Monoclonal / therapeutic use*
  • Antilymphocyte Serum / therapeutic use*
  • Cadaver
  • Costs and Cost Analysis
  • Graft Survival
  • Humans
  • Immunosuppression Therapy / methods*
  • Kidney Transplantation / methods*
  • Muromonab-CD3
  • Prospective Studies
  • Survival Analysis

Substances

  • Antibodies, Monoclonal
  • Antilymphocyte Serum
  • Muromonab-CD3